1. Bragg-Gresham, J. L., Greenwood, R., Akizawa, T., Kurokawa, K., Bailie, G. R., Gillespie, B. W., Keen, M. L., & Young, E. W. (2003). Significant variation exists among the number of medications prescribed for hemodialysis patients across countries: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Journal of the American Society of Nephrology, 14, 833A.
2. Centers for Medicare & Medicaid Services (CMS). (2003). Program Memorandum Intermediaries/Carriers, Transmittal AB-03-001.
3. Centers for Medicare & Medicaid Services (CMS). (2004). 2004 annual report: ESRD clinical performance measures project. Baltimore, MD: Department of Health and Human Services, Centers for Medicare & Medicaid Services, Office of Clinical Standards and Quality.
4. Centers for Medicare & Medicaid Services (CMS). (2005). National Health Expenditure Data. Table 1: National Health Expenditures Aggregate, Per Capita Amounts, Percent Distribution, and Average Annual Percent Growth, by Source of Funds: Selected Calendar Years 1960–2005. Retrieved February 9, 2007, from http://www.cms.hhs.gov/NationalHealthExpendData/downloads/tables.pdf.
5. Dor, A., Pauly, M.V., Eichleay, M.A., & Held, P.J. (2007). End-stage renal disease and economic incentives: The International Study of Health Care Organization and Financing (ISHCOF). International Journal of Health Financing and Economics, DOI: 10.1007/s10754-007-9024-9